Highly efficient in vivo hematopoietic stem cell transduction using an optimized self-complementary adeno-associated virus
Carsten T. Charlesworth(Stanford University), Hiromitsu Nakauchi(University of Tsukuba), Sicong Wang(Uppsala University), Agnieszka Czechowicz(Boston Children's Hospital), M. Kyle Cromer(Gladstone Institutes), Amanda M. Dudek(Stanford University), Adam C. Wilkinson(Wellcome/MRC Cambridge Stem Cell Institute), Carla Dib(Stanford University), Shota Homma(Stanford University), Kyomi J. Igarashi(California Institute for Regenerative Medicine), Fabian P. Suchy(California Institute for Regenerative Medicine), Alvaro Amorin(Stanford University), Sriram Vaidyanathan(Nationwide Children's Hospital), Anais K. Amaya(Stanford University), Yusuke Nakauchi(Stanford University), Masashi Miyauchi(California Institute for Regenerative Medicine), Tze-Kai Tan(Stanford University)
Cited by 3
Related Papers
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
|Cancer Cell|2018|255
Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers
|Hepatology|2012|195
Rapid Chromatin Switch in the Direct Reprogramming of Fibroblasts to Neurons
|Cell Reports|2017|146
Treatment of a genetic brain disease by CNS-wide microglia replacement
|Science Translational Medicine|2022|126
Sall4 Regulates Cell Fate Decision in Fetal Hepatic Stem/Progenitor Cells
|Gastroenterology|2008|106